Jaguar Health, Inc.
JAGX
$0.32
-$0.05-13.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.40M | -34.12M | -53.43M | -40.29M | -40.65M |
| Total Depreciation and Amortization | 2.16M | 2.18M | 2.20M | 2.25M | 2.29M |
| Total Amortization of Deferred Charges | 585.00K | 153.00K | 153.00K | 0.00 | 0.00 |
| Total Other Non-Cash Items | 12.61M | 10.40M | 10.88M | 9.47M | 10.35M |
| Change in Net Operating Assets | 14.35M | 13.85M | 16.51M | 2.55M | 325.00K |
| Cash from Operations | -6.69M | -7.54M | -23.69M | -26.02M | -27.68M |
| Capital Expenditure | -41.00K | -41.00K | -41.00K | -54.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -215.00K | -215.00K |
| Cash from Investing | -41.00K | -41.00K | -41.00K | -269.00K | -215.00K |
| Total Debt Issued | 10.00M | 10.00M | 13.45M | 3.45M | 3.45M |
| Total Debt Repaid | -7.10M | -6.95M | -752.00K | -753.00K | -775.00K |
| Issuance of Common Stock | 4.20M | 7.03M | 8.80M | 11.83M | 11.41M |
| Repurchase of Common Stock | -56.00K | -56.00K | -56.00K | -- | -- |
| Issuance of Preferred Stock | 4.20M | 2.38M | 2.38M | 2.38M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 56.00K | -308.00K | -145.00K | -191.00K | -95.00K |
| Cash from Financing | 11.30M | 12.09M | 23.67M | 16.71M | 13.98M |
| Foreign Exchange rate Adjustments | -187.00K | -132.00K | -113.00K | -159.00K | 68.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.38M | 4.37M | -170.00K | -9.74M | -13.84M |